We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNF icon
1351
Fidelity National Financial
FNF
$14.4B
$684K ﹤0.01%
+18,197
New +$614K
LPSN icon
1352
LivePerson
LPSN
$20.8M
$684K ﹤0.01%
+732
New +$629K
OTRK
1353
DELISTED
Ontrak
OTRK
$683K ﹤0.01%
123
+31
+34% +$169K
FICO icon
1354
Fair Isaac
FICO
$32.1B
$681K ﹤0.01%
1,333
-6,097
-82% -$2.84M
MFGP
1355
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$681K ﹤0.01%
+119,241
New +$516K
PBR.A icon
1356
Petrobras Class A
PBR.A
$103B
$679K ﹤0.01%
+61,351
New +$536K
VERI icon
1357
Veritone
VERI
$99.5M
$676K ﹤0.01%
+23,741
New +$411K
TOIIW
1358
CALL
The Oncology Institute Warrant
TOIIW
$4.45M
$675K ﹤0.01%
+62,492
New +$108K
AMP icon
1359
Ameriprise Financial
AMP
$48.6B
$673K ﹤0.01%
+3,461
New +$619K
TS icon
1360
Tenaris
TS
$27.9B
$673K ﹤0.01%
+42,146
New +$561K
GOLF icon
1361
Acushnet Holdings
GOLF
$6.01B
$668K ﹤0.01%
+16,481
New +$616K
SI
1362
DELISTED
Silvergate Capital Corporation
SI
$659K ﹤0.01%
+8,865
New +$292K
MAXR
1363
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$659K ﹤0.01%
17,090
+6,232
+57% +$183K
ASX icon
1364
ASE Group
ASX
$74.8B
$657K ﹤0.01%
+112,424
New +$561K
TBIO
1365
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$654K ﹤0.01%
35,485
-139,721
-80% -$2.5M
MAC icon
1366
Macerich
MAC
$7.48B
$652K ﹤0.01%
+61,118
New +$555K
PTR
1367
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$652K ﹤0.01%
+21,222
New +$649K
SBGI icon
1368
Sinclair Inc
SBGI
$1.01B
$651K ﹤0.01%
+20,430
New +$488K
LEAP
1369
DELISTED
Ribbit LEAP, Ltd.
LEAP
$649K ﹤0.01%
+49,970
New +$611K
STWD icon
1370
Starwood Property Trust
STWD
$6.18B
$646K ﹤0.01%
+33,499
New +$570K
LGND icon
1371
Ligand Pharmaceuticals
LGND
$5.96B
$638K ﹤0.01%
+10,283
New +$586K
XES icon
1372
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$359M
$637K ﹤0.01%
14,202
-2,304
-14% -$84K
TCRR
1373
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$634K ﹤0.01%
+20,504
New +$518K
NWN icon
1374
Northwest Natural Holdings
NWN
$2.21B
$631K ﹤0.01%
13,716
-7,112
-34% -$337K
GT icon
1375
Goodyear
GT
$2.11B
$626K ﹤0.01%
+57,323
New +$577K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.